Dr. Chapa’s OBGYN Clinical Pearls

Latest Episodes:

Monkeypox 101: Effect in Pregnancy and Beyond. Jun 13, 2022

Show notes

This is your crash course into all things “Monkeypox”. Data for this podcast comes from the CDC, WHO, and the Royal College of Obstetricians and Gynecologists. Information is moving fast and we’re here to keep you evidence-based. How does Monkeypox affect pregnancy? When is a C-Section indicated? What are the treatments available? And what about the 2 vaccines available in the USA… Why is one more problematic than the other? Listen in and find out.

Hydration for Oligo? Jun 09, 2022

Show notes

Which is better for determining amniotic fluid volume: the AFI or MVP? There’s data to support one or the other. In cases of isolated oligohydramnios in the late preterm interval, is there a role for maternal oral hydration? Does that actually work? We are going to dive into the amniotic fluid (no pun intended) dilemmas now.

Is Myfembree Birth Control? Jun 06, 2022

Show notes

According to the ACOG, by natural menopause it is estimated that up to 70% of women will have developed a uterine leiomyoma. 70%! Most of course are asymptomatic. For those with symptoms, heavy menstrual bleeding and pain are the most common afflictions. In May 2021, the FDA approved a new triple combination pill for heavy menstrual bleeding associated with fibroids. Can this medication also be used as hormonal birth control? We will review the ACOG, FDA, and manufacture’s information for MyFimbree in this clinical update.

Ganas! Jun 03, 2022

Show notes

Meet Hilda! In this quick episode, I’ll share a very unique story of one of our coworkers (our featured guest on the podcast). I know this will encourage, inspire, and just make your day! Listen in, and find out why.

Does the Progestin Matter? Jun 02, 2022

Show notes

There are currently (in the USA) 4 generations of available progestins in combination birth control pills. Are these differences clinically relevant, or is it all manufacturer marketing? In this session we will review the chemical nature, biology of, and clinical manifestations of the different progestins. We will set the record straight. (This topic was suggested by an OB/GYN senior resident at Lincoln Hospital, South Bronx… Thank you for listening to our podcast and for the wonderful podcast topic suggestion).

Fetal Microcephaly May 28, 2022

Show notes

Fetal microcephaly is a devastating diagnosis. Prognosis is dependent on whether fetal microcephaly is isolated or part of other congenital anomalies. Prognosis is also directly related to the degree of fetal microcephaly. In this session, we will review the diagnostic criteria, workup, and prognosis of this devastating fetal condition.

Update May 26, 2022

Show notes

Here’s what’s going on… As of May 26, 2022.

The Mask of Pregnancy May 21, 2022

Show notes

Pregnancy can definitely work some changes on the body. Melasma is a common pregnancy reaction, and can be a cosmetic concern to many affected. Are treatments safe to use during pregnancy? Are cutaneous lasers allowed? In this session we will review the available literature and cover the first, second, and third-line options for treatment of the mask of pregnancy.

The Non-Palpable Implant May 17, 2022

Show notes

The etonogestrel implant is the most effective LARC available. Well, how many years AFTER the FDA approval of 3 years does the implant remain effective? Also, currently, the usual and customary standard is for the provider and patient to palpate the implant area after insertion. But what happens when the insert is non-palpable? In the session, we will review the evidence-based protocol to find this nonpalpable implant. Can you order a serum etonogestrel level? Do these things “migrate”? Can a patient still use it for birth control after 3 years? Listen in, and find out.

Is Too Much FM Bad? May 12, 2022

Show notes

Historically, obstetrical providers cautioned patients about decreased fetal movement. But what about maternal perception of INCREASED fetal movement? Is increased fetal movement a harbinger of adverse neonatal outcome? In this session we will highlight and summarize a new publication from the AJOG (April 26, 2022) that helps shed light on this clinical conundrum.